RT Book, Section
A1 Chan, Samuel
SR Print(0)
ID 1184861361
T1 Adavosertib compared with active monitoring is potentially effective against TP53/RAS-mutant metastatic colorectal cancer.
T2 2 Minute Medicine
YR 2015
FD 2015
PB McGraw Hill
PP New York, NY
SN 
LK accessmedicina.mhmedical.com/updatesContent.aspx?gbosid=570617
RD 2024/04/19
AB